P d
<A nam >
<I Affiliation>
<C Num Nam >
<A D Date>
I Affiliation
I
P stre commonly
by a traumatic e .
T eve include; disasters, terr acts, serious
, ra , among other pr events.
T PTSD sy a blen of intrusive memories of
eve
U , a psy , must
at orga , , and molecular so as to treat
PTSD.
B H PTSD
H , PTSD tracea World W I
P g thi disorder seve depending it effe
society.
I commonly shell combat fa since the
in the of the disea .
T na combat fatig common since wa
the combat who to be a
B H PTSD ( )
●T vulnera the mili to PTSD is estimated
30% prone to these traumatic
they duty, (A , 2012).
●C molecular cellular me can be determined
preexisting traumatic for thi population.
●PTSD larg on the basis of patients’ , the
disorder wa with suspicion.
● of the neurobiolog mechanisms under
is the very .
P contributors
PTSD
T sev experienced
G po
H the
C sym (PTSD)
R - the traum
A o stim
,
A arou
S of PTSD
I or “E ” S .
D S .
S - R S .
L -t R S .
P of PTSD
D several brain ,
am
L co
H
N
H - -adrenal (HPA) .
M of treatme
P exposure
C PTSD
C therapy
E of develo PTSD
C ag fo PTSD are availab
P are at
estim 5 31 % PTSD
T g p ’ risk of
PTSD at 15%
P for
PTSD
H ( , skin
)
F EMG external, (M Farlane, al,
2017).
T -rel com sounds
M of traum
PTSD T M
T th ou
R the existing proto to
im treatm
T prov whereby
consid to m general
or outcom .
PTSD T M
C Behavior Therapy (CBT)
PTSD
P E (PE)
T SSRI sertraline app
the FDA PTSD
I PTSD T
E appraisals traum
T so ar both clinical
research
A p m criteria
taking com
diso .
P Fear Structure Related
PTSD
S are asso
R or during a traum
associated self-
C avo
R of PE in PTSD
T purpose of PE is to m
struc , (N , al,
2012).
T process is call proce
T appraisals of trauma prompt
cata
R
H , J. M., M , R. A., H , B. A., & H , J. L. (2017). W peo PTSD
do (and not) know PTSD: A . D anxiety,34(4),
374-382.
S , C. P., S , A. J., L , M., & J , R. T. (2018). N of PTSD
foll viol . P T : T , R , P ,
P ,10(1), 58.
T , Å. G., H , S. W., J , B. H., J , G. E., & B , P. T. (2018). T
h PTSD : A approach. M
P ,30(2), 142-151.
O'T , S. K., S , S. L., & B , S. A. (2016). A ‐ hypnother
the tre of PTSD . J trau ,29(1), 97-100.
A , W. (2012). P post-trau di in :
o ant . P T ,37(1), 32.
R
M Farl , A. C., L -W , E., V H , M., M , G. S., & Y , R. (2017). T to a
the PTSD a treatm . C ,19(2), 10.
C , M. A., L -W , E., M , G. S., & Y , R. (2017). T Ne to T Stag A
B M PTSD its T . C P R ,19(2).
N , S. B., M , U. S., W , K. C., G , A. A., H , V., H , Z., ... & R , S. K.
(2012). R pharm PTSD
. N ,62(2), 542-551.
Y , R., F , J. D., P , L. C., B , J., I , M., & H , F. (2010). P
the
PTSD. P ,212(3), 405-417.
K , T. R., & K , J. (2008). B disorder
. R developme alcoholis , 49-68.
